GlassScriptPhysician profile
Kevin J Denny
NPI 1427040732
$2,497.28
in general payments reported to CMS, 2019-2025
24 companies · $518 in 2025
The $518 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $226 · 2021: $194 · 2022: $315 · 2023: $408 · 2024: $240 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102 · Entertainment: $63.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.25 |
| Entertainment | $63.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $454.21 | 2019-2025 | Luxor, Rocklatan, Clareon |
| Allergan, INC. | $230.60 | 2019-2022 | |
| Abbvie INC. | $217.60 | 2022-2025 | |
| Carl Zeiss Meditec, INC. | $210.91 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $185.07 | 2019-2024 | Veritas Vision System, Tecnis Iol, Tecnis Simplicity |
| Carl Zeiss Meditec USA, INC. | $156.35 | 2021-2025 | Artevo 800 |
| Bausch & Lomb Americas INC. | $130.66 | 2023-2025 | Miebo, Envista Mx60 Iol, Vyzulta |
| Aerie Pharmaceuticals, INC. | $112.69 | 2019-2020 | |
| Rxsight INC | $110.16 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Tarsus Pharmaceuticals, INC. | $91.92 | 2024-2025 | Xdemvy |
| Thea Pharma INC. | $90.71 | 2023-2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $72.83 | 2019-2023 | Cequa |
| Optos, INC. | $63.30 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $57.37 | 2023-2025 | Tyrvaya, Ryzumvi |
| Dompe US, INC. | $56.10 | 2025 | Oxervate |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $42.30 | 2019-2020 | |
| Sight Sciences, INC. | $37.70 | 2019 | |
| Biotissue Holdings INC. | $36.63 | 2021 | |
| Omeros Corporation | $30.64 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $26.23 | 2020 | |
| Abb Con-Cise Optical Group LLC | $25.57 | 2021 | |
| New World Medical,INC. | $20.40 | 2022-2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Denny listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.